Sandra and Edward Meyer Cancer Center

You are here


Photo of Manish Shah, M.D.
2015 Feb 04

Onartuzumab for Gastroesophageal Adenocarcinoma

Manish A Shah, M.D., director of gastrointestinal oncology, discusses a recent phase II study of FOLFOX with or without onartuzumab, a MET inhibitor, for the treatment of metastatic gastroesophageal adenocarcinoma. Read more
Photo of bladder cancer patient Irene Price
2015 Jan 22

The new style of tailored treatment

Irene Price is an early beneficiary of “precision medicine,” an approach that replaces the traditional one-size-fits-all cancer treatment paradigm with one that focuses on targeted, individualized care using a patient’s own genetic profile and medical history. Read more
2015 Jan 15

A new paradigm: Precision medicine

Cancer: It’s personal, and not only on an emotional level, but a molecular one. Every patient's cancer is unique, driven by distinct biological factors. So, too, should every patient’s treatment. Read more


April 2015 

May 2015

June 2015

December 2015

February 2016

April 2016

July 2016

October 2016

February 2017

April 2017

July 2017

Cancer prevention at Weill Cornell Medicine, NewYork-Presbyterian Hospital in NY

Cancer Prevention Newsletter

Meyer Cancer Center is a partner with OncLive, the official Website for the Oncology Specialty Group.

Twitter Feed